Pharmaceutical companies have raised the prices of 43 generic drugs by at least 10% so far in the first half of 2018, according to an analysis from the investment bank Barclays. About half of those drugs are injectable generics used in hospitals, like vancomycin hydrochloride and heparin sodium.
Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.
More stories loading.